Major Program
US-Latin American-Caribbean U54
Research Group
Breast and Gynecologic Cancer
Sponsor
Fred Hutchinson Cancer Center
Status
Active, not recruiting
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT04265950
This phase IV trial compares 3 different dosing schedules to find the optimal number of doses for HPV vaccination in children and adolescents living with HIV. Comparing 3 different dosing schedules may help researchers determine whether a single dose of HPV vaccine could be effective in preventing HPV in children and adolescents living with HIV.
Intervention
Recombinant Human Papillomavirus Nonavalent Vaccine
Condition
HIV Infection
Investigators
Ann Duerr, MD, PhD